BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24793135)

  • 1. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.
    Kohsaka S; Shukla N; Ameur N; Ito T; Ng CK; Wang L; Lim D; Marchetti A; Viale A; Pirun M; Socci ND; Qin LX; Sciot R; Bridge J; Singer S; Meyers P; Wexler LH; Barr FG; Dogan S; Fletcher JA; Reis-Filho JS; Ladanyi M
    Nat Genet; 2014 Jun; 46(6):595-600. PubMed ID: 24793135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Reported Case of Malignant Ectomesenchymoma with p.Leu122Arg Mutation in MYOD1 Gene: Extensive Intra- and Extracranial Tumor in a 15-Year-Old Female.
    Pena-Burgos EM; De Sabando DP; Utrilla C; Pozo-Kreilinger JJ; Sastre A; Rubio P; Escudero A; Mendiola-Sabio M; Pérez-Martínez A
    Head Neck Pathol; 2023 Sep; 17(3):855-863. PubMed ID: 36913073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma.
    Saoud C; Dermawan JK; Sharma AE; Tap W; Wexler LH; Antonescu CR
    Genes Chromosomes Cancer; 2024 May; 63(5):e23238. PubMed ID: 38722224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation profiling reveals novel molecular classes of rhabdomyosarcoma.
    Clay MR; Patel A; Tran Q; Hedges DJ; Chang TC; Stewart E; Charville G; Cline C; Dyer MA; Orr BA
    Sci Rep; 2021 Nov; 11(1):22213. PubMed ID: 34782706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Myogenic Differentiation Improves Chemosensitivity of Chemoresistant Cells in Soft-Tissue Sarcoma Cell Lines.
    Dawson LE; D'Agostino L; Hakim AA; Lackman RD; Brown SA; Sensenig RB; Antonello ZA; Kuzin II
    Sarcoma; 2020; 2020():8647981. PubMed ID: 32300280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporadic hemangioblastomas are characterized by cryptic VHL inactivation.
    Shankar GM; Taylor-Weiner A; Lelic N; Jones RT; Kim JC; Francis JM; Abedalthagafi M; Borges LF; Coumans JV; Curry WT; Nahed BV; Shin JH; Paek SH; Park SH; Stewart C; Lawrence MS; Cibulskis K; Thorner AR; Van Hummelen P; Stemmer-Rachamimov AO; Batchelor TT; Carter SL; Hoang MP; Santagata S; Louis DN; Barker FG; Meyerson M; Getz G; Brastianos PK; Cahill DP
    Acta Neuropathol Commun; 2014 Dec; 2():167. PubMed ID: 25589003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
    Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
    Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
    Seki M; Nishimura R; Yoshida K; Shimamura T; Shiraishi Y; Sato Y; Kato M; Chiba K; Tanaka H; Hoshino N; Nagae G; Shiozawa Y; Okuno Y; Hosoi H; Tanaka Y; Okita H; Miyachi M; Souzaki R; Taguchi T; Koh K; Hanada R; Kato K; Nomura Y; Akiyama M; Oka A; Igarashi T; Miyano S; Aburatani H; Hayashi Y; Ogawa S; Takita J
    Nat Commun; 2015 Jul; 6():7557. PubMed ID: 26138366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNF43 is frequently mutated in colorectal and endometrial cancers.
    Giannakis M; Hodis E; Jasmine Mu X; Yamauchi M; Rosenbluh J; Cibulskis K; Saksena G; Lawrence MS; Qian ZR; Nishihara R; Van Allen EM; Hahn WC; Gabriel SB; Lander ES; Getz G; Ogino S; Fuchs CS; Garraway LA
    Nat Genet; 2014 Dec; 46(12):1264-6. PubMed ID: 25344691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.
    Martin D; Abba MC; Molinolo AA; Vitale-Cross L; Wang Z; Zaida M; Delic NC; Samuels Y; Lyons JG; Gutkind JS
    Oncotarget; 2014 Oct; 5(19):8906-23. PubMed ID: 25275298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational landscape of aggressive cutaneous squamous cell carcinoma.
    Pickering CR; Zhou JH; Lee JJ; Drummond JA; Peng SA; Saade RE; Tsai KY; Curry JL; Tetzlaff MT; Lai SY; Yu J; Muzny DM; Doddapaneni H; Shinbrot E; Covington KR; Zhang J; Seth S; Caulin C; Clayman GL; El-Naggar AK; Gibbs RA; Weber RS; Myers JN; Wheeler DA; Frederick MJ
    Clin Cancer Res; 2014 Dec; 20(24):6582-92. PubMed ID: 25303977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases.
    Alaggio R; Zhang L; Sung YS; Huang SC; Chen CL; Bisogno G; Zin A; Agaram NP; LaQuaglia MP; Wexler LH; Antonescu CR
    Am J Surg Pathol; 2016 Feb; 40(2):224-35. PubMed ID: 26501226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A MYOD1 mutation cooperates with PI3K pathway activation in ERMS.
    Cancer Discov; 2014 Jul; 4(7):OF19. PubMed ID: 25002625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.
    Shain AH; Garrido M; Botton T; Talevich E; Yeh I; Sanborn JZ; Chung J; Wang NJ; Kakavand H; Mann GJ; Thompson JF; Wiesner T; Roy R; Olshen AB; Gagnon A; Gray JW; Huh N; Hur JS; Busam KJ; Scolyer RA; Cho RJ; Murali R; Bastian BC
    Nat Genet; 2015 Oct; 47(10):1194-9. PubMed ID: 26343386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.
    Li M; Zhang Z; Li X; Ye J; Wu X; Tan Z; Liu C; Shen B; Wang XA; Wu W; Zhou D; Zhang D; Wang T; Liu B; Qu K; Ding Q; Weng H; Ding Q; Mu J; Shu Y; Bao R; Cao Y; Chen P; Liu T; Jiang L; Hu Y; Dong P; Gu J; Lu W; Shi W; Lu J; Gong W; Tang Z; Zhang Y; Wang X; Chin YE; Weng X; Zhang H; Tang W; Zheng Y; He L; Wang H; Liu Y; Liu Y
    Nat Genet; 2014 Aug; 46(8):872-6. PubMed ID: 24997986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.
    Wang K; Yuen ST; Xu J; Lee SP; Yan HH; Shi ST; Siu HC; Deng S; Chu KM; Law S; Chan KH; Chan AS; Tsui WY; Ho SL; Chan AK; Man JL; Foglizzo V; Ng MK; Chan AS; Ching YP; Cheng GH; Xie T; Fernandez J; Li VS; Clevers H; Rejto PA; Mao M; Leung SY
    Nat Genet; 2014 Jun; 46(6):573-82. PubMed ID: 24816253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.
    Kakiuchi M; Nishizawa T; Ueda H; Gotoh K; Tanaka A; Hayashi A; Yamamoto S; Tatsuno K; Katoh H; Watanabe Y; Ichimura T; Ushiku T; Funahashi S; Tateishi K; Wada I; Shimizu N; Nomura S; Koike K; Seto Y; Fukayama M; Aburatani H; Ishikawa S
    Nat Genet; 2014 Jun; 46(6):583-7. PubMed ID: 24816255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.
    Krauthammer M; Kong Y; Bacchiocchi A; Evans P; Pornputtapong N; Wu C; McCusker JP; Ma S; Cheng E; Straub R; Serin M; Bosenberg M; Ariyan S; Narayan D; Sznol M; Kluger HM; Mane S; Schlessinger J; Lifton RP; Halaban R
    Nat Genet; 2015 Sep; 47(9):996-1002. PubMed ID: 26214590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genomic landscape of pediatric Ewing sarcoma.
    Crompton BD; Stewart C; Taylor-Weiner A; Alexe G; Kurek KC; Calicchio ML; Kiezun A; Carter SL; Shukla SA; Mehta SS; Thorner AR; de Torres C; Lavarino C; Suñol M; McKenna A; Sivachenko A; Cibulskis K; Lawrence MS; Stojanov P; Rosenberg M; Ambrogio L; Auclair D; Seepo S; Blumenstiel B; DeFelice M; Imaz-Rosshandler I; Schwarz-Cruz Y Celis A; Rivera MN; Rodriguez-Galindo C; Fleming MD; Golub TR; Getz G; Mora J; Stegmaier K
    Cancer Discov; 2014 Nov; 4(11):1326-41. PubMed ID: 25186949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative clinical genomics of advanced prostate cancer.
    Robinson D; Van Allen EM; Wu YM; Schultz N; Lonigro RJ; Mosquera JM; Montgomery B; Taplin ME; Pritchard CC; Attard G; Beltran H; Abida W; Bradley RK; Vinson J; Cao X; Vats P; Kunju LP; Hussain M; Feng FY; Tomlins SA; Cooney KA; Smith DC; Brennan C; Siddiqui J; Mehra R; Chen Y; Rathkopf DE; Morris MJ; Solomon SB; Durack JC; Reuter VE; Gopalan A; Gao J; Loda M; Lis RT; Bowden M; Balk SP; Gaviola G; Sougnez C; Gupta M; Yu EY; Mostaghel EA; Cheng HH; Mulcahy H; True LD; Plymate SR; Dvinge H; Ferraldeschi R; Flohr P; Miranda S; Zafeiriou Z; Tunariu N; Mateo J; Perez-Lopez R; Demichelis F; Robinson BD; Schiffman M; Nanus DM; Tagawa ST; Sigaras A; Eng KW; Elemento O; Sboner A; Heath EI; Scher HI; Pienta KJ; Kantoff P; de Bono JS; Rubin MA; Nelson PS; Garraway LA; Sawyers CL; Chinnaiyan AM
    Cell; 2015 May; 161(5):1215-1228. PubMed ID: 26000489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.